As summer approaches, pharmacy staff may begin to field more questions about how patients can manage their health and their medications while they travel, especially during extended travel abroad.

Sonya Collins

Chronic pain is common and debilitating, and its treatment continues to present challenges to the medical community.

Sonya Collins

There is an expanding variety of home testing and monitoring kits available for patients interested in preventative care, detecting the presence or absence of a medical or physiologic condition, and monitoring therapy or results of a wellness routine.

A federal judge in Ohio who oversees the National Prescription Opiate Litigation (NPOL) has recently issued a ruling with significant implications for pharmacists and pharmacies.

David B. Brushwood, BSPharm, JD

The initial shock of the COVID-19 pandemic has worn off. Fast forward 3 years later to today, and a clearer picture has emerged of both the individual as well as broader organizational effects of prolonged stress from the pandemic. Some pharmacy personnel are leaving, others are experiencing apathy, and there are clear threats to patient safety.

Last October, Adderall (amphetamine/dextroamphetamine) and its generics entered shortage status. As prescribers scrambled to find alternatives for their adult and pediatric patients with ADHD, many other central nervous system stimulants have seen intermittent shortages as well.

In March 2023, FDA approved naloxone for OTC sale in a move that public health experts hope will dramatically increase access to the nasal spray and slash opioid overdose deaths.

The community pharmacy may be the very place where addressing social determinants of health (SDOH) can be a reality, not just a concept.

Many patients seek OTC relief for skin injuries each year.

A federal court in Missouri recently granted a pharmacist’s motion for a preliminary injunction after the pharmacist asserted that her constitutional right to free speech was infringed by a recently enacted state statute.